Cargando…
Hematopoietic Stem Cell Therapy for Wiskott–Aldrich Syndrome: Improved Outcome and Quality of Life
The Wiskott–Aldrich syndrome (WAS) is an X-linked disorder caused by mutations in the WAS gene resulting in congenital thrombocytopenia, eczema, recurrent infections and an increased incidence of autoimmune diseases and malignancies. Without curative therapies, affected patients have diminished life...
Autores principales: | Mallhi, Kanwaldeep K, Petrovic, Aleksandra, Ochs, Hans D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206065/ https://www.ncbi.nlm.nih.gov/pubmed/34149291 http://dx.doi.org/10.2147/JBM.S232650 |
Ejemplares similares
-
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
por: Rai, Rajeev, et al.
Publicado: (2020) -
Unraveling the Repertoire in Wiskott–Aldrich Syndrome
por: Petersen, Sven H., et al.
Publicado: (2014) -
Síndrome de Wiskott - Aldrich /
por: Tello Gabriel, Adriana -
Autoimmunity in Wiskott–Aldrich Syndrome: An Unsolved Enigma
por: Catucci, Marco, et al.
Publicado: (2012) -
Autoimmunity in Wiskott–Aldrich Syndrome: Updated Perspectives
por: Sudhakar, Murugan, et al.
Publicado: (2021)